Use http://trasylol-aprotinin.legalview.com to garner more information on this ongoing investigation. Also use LegalView's other information portals to learn about controversial drugs similar to Trasylol Aprotinin such as the Avandia risks, found at http://avandia.legalview.com, or the Vytorin and Zetia side effects.
How does a drug marketed by a pharmaceutical giant go from superstar to scapegoat in a matter of mere months? That's what doctors who use the injectable drug Trasylol-Aprotinin are asking themselves after recent revelations that the drug, which is used to stop bleeding in 60 percent of heart surgery patients, causes side effects such as kidney failure, heart attack, encephalopathy, stroke and even death.
The New England Journal of Medicine study published in 2006 reported that after being administered Trasylol-Aprotinin, patients risk of renal failure, stroke, death and heart attack increased by 259 percent; at that point the drug had already been manufactured by Bayer AG for 13 years, since 1993.
Singing Its Praises
Ironically, the drug had been mentioned in The Washington Post in early January 2006 as an example of a drug so safe that it no longer required clinical study. The Washington Post article reported that after 12 of 64 clinical trials, Trasylol's positive advantages over other drugs was clear, as the article claimed blood transfusion ins among bypass patients decreased by nearly one-third. The article also included information that suggested if scientists had used the previous results of the drug, which were positive, then additional clinical trials would not have been necessary.
Tides Turn for Trasylol
The above article ran on January 2, 2006. However, once the New England Journal of Medicine study on Trasylol-Aprotinin was published on the risks of approximately 1,000 heart surgery patients, the drug's use began to diminish. Once the study was published, the U.S. Food and Drug Administration (FDA) began investigating the alleged side effects and, even after protests by Bayer officials claiming the results of the study were inaccurate, the FDA began discouraging the use of Trasylol-Aprotinin among patients.
Though Bayer has tried to discredit this study and market the drug for other procedures (including hip replacement surgery), lawsuits have begun to flow in as more and more patients have been found who have experienced detrimental side effects from the use of Trasylol-Aprotinin in their heart surgeries.
Have You Suffered Side Effects?
Gaining the perspective of an experience pharmaceutical attorney who can consult you on your experience with Trasylol-Aprotinin will allow the potential for monetary compensation for the costly medical bills attributed to these damaging side effects. Contact an experienced pharmaceutical attorney who can help you evaluate your claim and attain the compensation you deserve.
- Related Articles
- Related Q&A
- Manufacturer of Trasylol, Bayer Ag, Finds Increased Risk of Death, Removes Trasylol From Shelves
- Trasylol Manufacturer Removes Trasylol from Shelves after Increased Risk of Death Found
- Hire the Trasylol Lawsuit Attorney Able to Bring Justice to Your Case
- Trasylol Class Action Lawsuit for Trasylol Heart Surgery Stroke Problems
- The Truth of Trasylol Aprotinin
- Controversy Over Side Effects of Trasylol Injections
- Trasylol Injections May Cause Stroke, Death
- Trasylol Story A Sea Change For Medical Community
Cleanse Yourself With A Body Detox
By: Mark Walters | 04/01/2010Useful information and advice on detoxing. Find out why a body detox is necessary and what the benefits of one are.
cycloserine
By: michaelrussell | 04/01/2010Inhibits cell-wall biosynthesis by interfering with the bacterial use of amino acids. Action may be bacteriostatic or bactcricidal, depending on the concentration of drug attained at the site of infection and tile susceptibility of the infecting organism.
Counseling With a Subconscious Restructuring® Life Coach For Permanent Weight Loss in 2010
By: Kelly Burris, PhD | 04/01/2010Does one usually find something that one has lost? This is the case with most people whom attempt permanent weight loss. More than half of all Americans are continually dieting. Over 50 billion dollars is spent each year in the weight loss and diet market. This market continues to grow...
Imipenem and cilastatin sodium
By: michaelrussell | 04/01/2010HOW SUPPLIED Powder for injection: 250 mg, 500 mg, 750 mg ACTION Imipenem is bactericidal and inhibits bacterial cell-wall synthesis. Cilastatin inhibits the enzymatic breakdown of irnipenem in the kidneys, thereby achieving adequate antibacterial levels of imipenem in the urine.
Osteopath Putney: Sports Injuries
By: Shivangi Mehra | 04/01/2010With every sports injury, there is recovery time involved. Find out more about sports injuries, and what you can do to prevent them, and help the recovery along.
cycloserine
By: michaelrussell | 04/01/2010Inhibits cell-wall biosynthesis by interfering with the bacterial use of amino acids. Action may be bacteriostatic or bactcricidal, depending on the concentration of drug attained at the site of infection and tile susceptibility of the infecting organism.
Acquired Brain Injury
By: sean sandvik | 04/01/2010There are two main ways brain injury can occur, insidious onset (tumors, neurological diseases, and substance and alcohol abuse) or outside onset (infection, lack of oxygen, trauma, and strokes). Acquired Brain Injury (ABI) is brain damage suffered after birth.
hydroxychloroquine sulfate
By: michaelrussell | 04/01/2010HOW SUPPLIED Tablets: 200 mg (155-mg base) ACTION Unknown, May bind to and alter the properties of DNA in susceptible organisms. INDICATIONS 8. DOSAGE Suppressive prophylaxis of'malaria attacks due to Plasmodium vivax, P malariae, P. ovale, and susceptible strains of P. falciparum- Adults: 400 mg (310-mgbase) PO. weekly on same day of week (begin I to 2 weeks before entering endemic area and continue for 4 weeks after leaving endemic area). If not started before exposure, init
Construction Dangers Pose a Threat to Increased Eye Injuries On the Job
By: Peter Kent | 10/06/2009 | HealthWorker protective agencies have determined that construction site eye injuries and accidents are abundant on a construction site. Eye injuries are common among many jobs, but construction site eye injuries are among the highest.
Guidelines Not Followed With Avandia Manufacturering
By: Peter Kent | 10/06/2009 | Healthccording to the U.S. Food and Drug Administration and the Wall Street Journal, a series of mistakes were made while conducting an avandia clinical trial, which may have put individuals at an increased risk for potential side effects.
Reports Surface Linking Brain Injury and Development of Alzheimer's Disease
By: Peter Kent | 09/06/2009 | HealthResearchers at Georgetown University Medical center may have found a link between traumatic brain injury patients and the onset of Alzheimer's as a result from potential injuries.
Peanut Butter Recall Estimated to Cost Close to $1 Billion
By: Peter Kent | 09/06/2009 | Home & FamilyAccording to news reports the recent peanut butter recall that sickened hundreds of Americans, will likely cost $1 billion overall. The recall reached a level of being investigated by the U.S. Food and Drug Administration (FDA).
Mesothelioma Treatment to Receive Further Testing
By: Peter Kent | 27/05/2009 | HealthRecent research deriving from Columbia University has found that two new drugs, currently being tested, may become suitable treatments for individuals suffering from pleural and malignant mesothelioma.
Journal Reports Dangers Of Nsaids
By: Peter Kent | 01/03/2009 | HealthRecently, a medical journal discovered more harmful side effects among patients consuming nonsteroidal anti-inflammatory drugs (NSAIDs) than helpful side effects among heart failure patients.
Florida Truck Driving Deemed Deadliest Job in State
By: Peter Kent | 09/02/2009 | AutomotiveIndividuals who currently work in the truck driving/transportation industry in Florida recently received a blow to their profession after it was listed as the top deadliest profession in the state.
Mesothelioma Treatment Dosage Levels Researched by Physicians
By: Peter Kent | 09/02/2009 | HealthResearchers are attempting to increase the validity of mesothelioma treatments among patients suffering from the fatal condition by testing the highest dosage levels that can be administered to patients without resulting in toxicity levels among individuals.